Fair Value Measurement |
Fair value measurement Refer to Note 2 of JPMorganChase’s 2024 Form 10-K for a discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy. The following table presents the assets and liabilities reported at fair value as of June 30, 2025 and December 31, 2024, by major product category and fair value hierarchy. | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets and liabilities measured at fair value on a recurring basis | | | | | | | | | Fair value hierarchy | | Derivative netting adjustments(e) | | | | | | | | | | June 30, 2025 (in millions) | Level 1 | | Level 2 | | Level 3 | | Total fair value | Federal funds sold and securities purchased under resale agreements | $ | — | | | $ | 447,781 | | | $ | — | | | $ | — | | $ | 447,781 | | Securities borrowed | — | | | 96,645 | | | — | | | — | | 96,645 | | Trading assets: | | | | | | | | | Debt instruments: | | | | | | | | | Mortgage-backed securities: | | | | | | | | | U.S. GSEs and government agencies(a) | — | | | 158,847 | | | 365 | | | — | | 159,212 | | Residential – nonagency | — | | | 2,691 | | | 5 | | | — | | 2,696 | | Commercial – nonagency | — | | | 1,476 | | | 7 | | | — | | 1,483 | | Total mortgage-backed securities | — | | | 163,014 | | | 377 | | | — | | 163,391 | | U.S. Treasury, GSEs and government agencies(a) | 195,415 | | | 14,558 | | | — | | | — | | 209,973 | | Obligations of U.S. states and municipalities | — | | | 6,499 | | | 1 | | | — | | 6,500 | | Certificates of deposit, bankers’ acceptances and commercial paper | — | | | 4,963 | | | — | | | — | | 4,963 | | Non-U.S. government debt securities | 63,424 | | | 72,207 | | | 205 | | | — | | 135,836 | | Corporate debt securities | — | | | 45,252 | | | 385 | | | — | | 45,637 | | Loans | — | | | 11,919 | | | 868 | | | — | | 12,787 | | Asset-backed securities | — | | | 4,839 | | | 12 | | | — | | 4,851 | | Total debt instruments | 258,839 | | | 323,251 | | | 1,848 | | | — | | 583,938 | | Equity securities | 222,091 | | | 1,213 | | | 196 | | | — | | 223,500 | | Physical commodities(b) | 6,465 | | | 1,213 | | | 24 | | | — | | 7,702 | | Other | — | | | 14,153 | | | 217 | | | — | | 14,370 | | Total debt and equity instruments(c) | 487,395 | | | 339,830 | | | 2,285 | | | — | | 829,510 | | Derivative receivables: | | | | | | | | | Interest rate | 3,844 | | | 302,121 | | | 4,341 | | | (284,836) | | 25,470 | | Credit | — | | | 10,774 | | | 894 | | | (11,180) | | 488 | | Foreign exchange | 172 | | | 211,373 | | | 1,690 | | | (189,527) | | 23,708 | | Equity | — | | | 99,199 | | | 3,029 | | | (96,969) | | 5,259 | | Commodity | — | | | 18,893 | | | 505 | | | (13,977) | | 5,421 | | Total derivative receivables | 4,016 | | | 642,360 | | | 10,459 | | | (596,489) | | 60,346 | | Total trading assets(d) | 491,411 | | | 982,190 | | | 12,744 | | | (596,489) | | 889,856 | | Available-for-sale securities: | | | | | | | | | Mortgage-backed securities: | | | | | | | | | U.S. GSEs and government agencies(a) | — | | | 94,035 | | | — | | | — | | 94,035 | | Residential – nonagency | — | | | 5,955 | | | — | | | — | | 5,955 | | Commercial – nonagency | — | | | 4,861 | | | 7 | | | — | | 4,868 | | Total mortgage-backed securities | — | | | 104,851 | | | 7 | | | — | | 104,858 | | U.S. Treasury and government agencies | 302,794 | | | 287 | | | — | | | — | | 303,081 | | Obligations of U.S. states and municipalities | — | | | 17,647 | | | — | | | — | | 17,647 | | Non-U.S. government debt securities | 32,875 | | | 8,255 | | | — | | | — | | 41,130 | | Corporate debt securities | — | | | 31 | | | 92 | | | — | | 123 | | Asset-backed securities: | | | | | | | | | Collateralized loan obligations | — | | | 16,460 | | | — | | | — | | 16,460 | | Other(a) | — | | | 2,081 | | | — | | | — | | 2,081 | | Total available-for-sale securities | 335,669 | | | 149,612 | | | 99 | | | — | | 485,380 | | Loans | — | | | 51,048 | | | 2,252 | | | — | | 53,300 | | Mortgage servicing rights | — | | | — | | | 8,996 | | | — | | 8,996 | | Other assets(d) | 7,915 | | | 7,552 | | | 1,403 | | | — | | 16,870 | | Total assets measured at fair value on a recurring basis | $ | 834,995 | | | $ | 1,734,828 | | | $ | 25,494 | | | $ | (596,489) | | $ | 1,998,828 | | Deposits | $ | — | | | $ | 39,536 | | | $ | 2,099 | | | $ | — | | $ | 41,635 | | Federal funds purchased and securities loaned or sold under repurchase agreements | — | | | 525,477 | | | — | | | — | | 525,477 | | Short-term borrowings | — | | | 32,263 | | | 4,136 | | | — | | 36,399 | | Trading liabilities: | | | | | | | | | Debt and equity instruments(c) | 136,079 | | | 37,141 | | | 72 | | | — | | 173,292 | | Derivative payables: | | | | | | | | | Interest rate | 5,552 | | | 282,157 | | | 2,910 | | | (281,263) | | 9,356 | | Credit | — | | | 15,445 | | | 1,702 | | | (14,321) | | 2,826 | | Foreign exchange | 183 | | | 204,312 | | | 1,350 | | | (189,448) | | 16,397 | | Equity | — | | | 116,044 | | | 6,233 | | | (107,348) | | 14,929 | | Commodity | — | | | 16,124 | | | 336 | | | (11,858) | | 4,602 | | Total derivative payables | 5,735 | | | 634,082 | | | 12,531 | | | (604,238) | | 48,110 | | Total trading liabilities | 141,814 | | | 671,223 | | | 12,603 | | | (604,238) | | 221,402 | | Accounts payable and other liabilities | 5,289 | | | 3,606 | | | 40 | | | — | | 8,935 | | Beneficial interests issued by consolidated VIEs | — | | | 7 | | | — | | | — | | 7 | | Long-term debt | — | | | 76,693 | | | 41,664 | | | — | | 118,357 | | Total liabilities measured at fair value on a recurring basis | $ | 147,103 | | | $ | 1,348,805 | | | $ | 60,542 | | | $ | (604,238) | | $ | 952,212 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value hierarchy | | Derivative netting adjustments(e) | | | | | | | | | | | | December 31, 2024 (in millions) | Level 1 | | Level 2 | | Level 3 | | | Total fair value | Federal funds sold and securities purchased under resale agreements | $ | — | | | $ | 286,771 | | | $ | — | | | $ | — | | | $ | 286,771 | | Securities borrowed | — | | | 83,962 | | | — | | | — | | | 83,962 | | Trading assets: | | | | | | | | | | Debt instruments: | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | U.S. GSEs and government agencies(a) | — | | | 104,312 | | | 488 | | | — | | | 104,800 | | Residential – nonagency | — | | | 2,282 | | | 5 | | | — | | | 2,287 | | Commercial – nonagency | — | | | 1,283 | | | 10 | | | — | | | 1,293 | | Total mortgage-backed securities | — | | | 107,877 | | | 503 | | | — | | | 108,380 | | U.S. Treasury, GSEs and government agencies(a) | 150,580 | | | 11,702 | | | — | | | — | | | 162,282 | | Obligations of U.S. states and municipalities | — | | | 6,100 | | | 1 | | | — | | | 6,101 | | Certificates of deposit, bankers’ acceptances and commercial paper | — | | | 3,950 | | | — | | | — | | | 3,950 | | Non-U.S. government debt securities | 34,108 | | | 54,335 | | | 152 | | | — | | | 88,595 | | Corporate debt securities | — | | | 33,591 | | | 390 | | | — | | | 33,981 | | Loans | — | | | 10,228 | | | 1,088 | | | — | | | 11,316 | | Asset-backed securities | — | | | 2,813 | | | 10 | | | — | | | 2,823 | | Total debt instruments | 184,688 | | | 230,596 | | | 2,144 | | | — | | | 417,428 | | Equity securities | 130,307 | | | 1,359 | | | 62 | | | — | | | 131,728 | | Physical commodities(b) | 5,957 | | | 1,533 | | | 26 | | | — | | | 7,516 | | Other | — | | | 19,935 | | | 210 | | | — | | | 20,145 | | Total debt and equity instruments(c) | 320,952 | | | 253,423 | | | 2,442 | | | — | | | 576,817 | | Derivative receivables: | | | | | | | | | | Interest rate | 4,934 | | | 282,019 | |
| 3,781 | | | (265,789) | | | 24,945 | | Credit | — | | | 10,379 | | | 708 | | | (10,273) | | | 814 | | Foreign exchange | 196 | | | 261,520 | |
| 1,204 | | | (237,608) | | | 25,312 | | Equity | — | | | 82,855 | | | 2,365 | | | (79,935) | | | 5,285 | | Commodity | — | | | 15,232 | | | 394 | | | (11,015) | | | 4,611 | | Total derivative receivables | 5,130 | | | 652,005 | |
| 8,452 | | | (604,620) | | | 60,967 | | Total trading assets(d) | 326,082 | | | 905,428 | |
| 10,894 | | | (604,620) | | | 637,784 | | Available-for-sale securities: | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | U.S. GSEs and government agencies(a) | — | | | 91,893 | | | — | | | — | | | 91,893 | | Residential – nonagency | — | | | 4,811 | | | — | | | — | | | 4,811 | | Commercial – nonagency | — | | | 4,057 | | | 8 | | | — | | | 4,065 | | Total mortgage-backed securities | — | | | 100,761 | | | 8 | | | — | | | 100,769 | | U.S. Treasury and government agencies | 234,491 | | | 288 | | | — | | | — | | | 234,779 | | Obligations of U.S. states and municipalities | — | | | 17,913 | | | — | | | — | | | 17,913 | | Non-U.S. government debt securities | 23,973 | | | 12,272 | | | — | | | — | | | 36,245 | | Corporate debt securities | — | | | 70 | | | — | | | — | | | 70 | | Asset-backed securities: | | | | | | | | | | Collateralized loan obligations | — | | | 14,943 | | | — | | | — | | | 14,943 | | Other(a) | — | | | 2,133 | | | — | | | — | | | 2,133 | | Total available-for-sale securities | 258,464 | | | 148,380 | | | 8 | | | — | | | 406,852 | | Loans | — | | | 38,934 | | | 2,416 | | | — | | | 41,350 | | Mortgage servicing rights | — | | | — | | | 9,121 | | | — | | | 9,121 | | Other assets(d) | 5,732 | | | 6,997 | | | 1,344 | | | — | | | 14,073 | | Total assets measured at fair value on a recurring basis | $ | 590,278 | | | $ | 1,470,472 | |
| $ | 23,783 | |
| $ | (604,620) | | | $ | 1,479,913 | | Deposits | $ | — | | | $ | 31,583 | | | $ | 2,185 | | | $ | — | | | $ | 33,768 | | Federal funds purchased and securities loaned or sold under repurchase agreements | — | | | 226,329 | | | — | | | — | | | 226,329 | | Short-term borrowings | — | | | 23,045 | | | 3,476 | | | — | | | 26,521 | | Trading liabilities: | | | | | | | | | | Debt and equity instruments(c) | 120,719 | | | 32,457 | | | 46 | | | — | | | 153,222 | | Derivative payables: | | | | | | | | | | Interest rate | 3,981 | | | 266,767 | |
| 3,480 | | | (264,989) | | | 9,239 | | Credit | — | | | 12,725 | |
| 1,071 | | | (11,898) | | | 1,898 | | Foreign exchange | 187 | | | 253,196 | |
| 1,184 | | | (238,970) | | | 15,597 | | Equity | — | | | 90,908 | |
| 5,231 | | | (87,491) | | | 8,648 | | Commodity | — | | | 14,021 | |
| 467 | | | (10,209) | | | 4,279 | | Total derivative payables | 4,168 | | | 637,617 | |
| 11,433 | | | (613,557) | | | 39,661 | | Total trading liabilities | 124,887 | | | 670,074 | |
| 11,479 | | | (613,557) | | | 192,883 | | Accounts payable and other liabilities | 3,100 | | | 2,717 | |
| 76 | | | — | | | 5,893 | | Beneficial interests issued by consolidated VIEs | — | | | 1 | |
| — | | | — | | | 1 | | Long-term debt | — | | | 66,216 | |
| 34,564 | | | — | | | 100,780 | | Total liabilities measured at fair value on a recurring basis | $ | 127,987 | | | $ | 1,019,965 | |
| $ | 51,780 | | | $ | (613,557) | | | $ | 586,175 | |
(a)At June 30, 2025 and December 31, 2024, included total U.S. GSE obligations of $160.3 billion and $120.1 billion, respectively, which were mortgage-related. (b)Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. Refer to Note 4 for a further discussion of the Firm’s hedge accounting relationships. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented. (c)Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions). (d)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At June 30, 2025 and December 31, 2024, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $1.1 billion and $1.0 billion, respectively, primarily reported in other assets. (e)As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral. Level 3 valuations Refer to Note 2 of JPMorganChase’s 2024 Form 10-K for further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments. The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and the weighted or arithmetic averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy. The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value. In the Firm’s view, the input range, weighted and arithmetic average values do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted and arithmetic average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.
| | | | | | | | | | | | | | | | | | | | | | | | | | Level 3 inputs(a) | | | | | | | June 30, 2025 | | | | | | | Product/Instrument | Fair value (in millions) | | Principal valuation technique | Unobservable inputs(g) | Range of input values | | Average(i) | Residential mortgage-backed securities and loans(b) | $ | 843 | | | Discounted cash flows | Yield | 0% | | 93% | | 7% | | | | Prepayment speed | 2% | | 13% | | 9% | | | | | Conditional default rate | 0% | | 7% | | 0% | | | | | Loss severity | 0% | | 110% | | 5% | Commercial mortgage-backed securities and loans(c) | 1,299 | | | Market comparables | Price | $0 | | $84 | | $81 | Corporate debt securities | 477 | | | Market comparables | Price | $0 | | $197 | | $100 | Loans(d) | 1,362 | | | Market comparables | Price | $0 | | $101 | | $82 | Non-U.S. government debt securities | 205 | | | Market comparables | Price | $2 | | $121 | | $99 | Net interest rate derivatives | 1,422 | | | Option pricing | Interest rate volatility | 25 bps | | 695 bps | | 109 bps | | | | | Interest rate spread volatility | 37 bps | | 77 bps | | 64 bps | | | | | Bermudan switch value | 0% | | 45% | | 16% | | | | | Interest rate correlation | (64)% | | 97% | | 63% | | | | | IR-FX correlation | (35)% | | 60% | | 8% | | 9 | | | Discounted cash flows | Prepayment speed | 0% | | 20% | | 5% | Net credit derivatives | (837) | | | Discounted cash flows | Credit correlation | 27% | | 79% | | 47% | | | | | Credit spread | 0 bps | | 11,330 bps | | 547 bps | | | | | Recovery rate | 10% | | 90% | | 56% | | 29 | | | Market comparables | Price | $0 | | $115 | | $75 | Net foreign exchange derivatives | 390 | | | Option pricing | IR-FX correlation | (40)% | | 60% | | 21% | | (50) | | | Discounted cash flows | Prepayment speed | 11% | | 11% | | | | | Interest rate curve | 2% | | 28% | | 12% | Net equity derivatives | (3,204) | | | Option pricing | Forward equity price(h) | 82% | | 144% | | 101% | | | | | Equity volatility | 4% | | 198% | | 33% | | | | | Equity correlation | 5% | | 100% | | 55% | | | | | Equity-FX correlation | (80)% | | 65% | | (32)% | | | | | Equity-IR correlation | 5% | | 25% | | 12% | Net commodity derivatives | 169 | | | Option pricing | Oil commodity forward | $37 / BBL | | $287 / BBL | | $153 / BBL | | | | | Natural gas commodity forward | $2 / MMBTU | | $7 / MMBTU | | $4 / MMBTU | | | | | Commodity volatility | 2% | | 47% | | 6% | | | | | Commodity correlation | (15)% | | 98% | | 10% | MSRs | 8,996 | | | Discounted cash flows | Refer to Note 14 | | | Long-term debt, short-term borrowings, and deposits(e) | 46,889 | | | Option pricing | Interest rate volatility | 25 bps | | 695 bps | | 109 bps | | | | Bermudan switch value | 0% | | 45% | | 16% | | | | Interest rate correlation | (64)% | | 97% | | 63% | | | | IR-FX correlation | (35)% | | 60% | | 8% | | | | Equity volatility | 2% | | 111% | | 27% | | | | Equity correlation | 5% | | 100% | | 55% | | | | Equity-FX correlation | (80)% | | 65% | | (32)% | | | | Equity-IR correlation | 5% | | 25% | | 12% | | 1,010 | | | Discounted cash flows | Credit correlation | 26% | | 73% | | 47% | | | | | Credit spread | 1 bps | | 273 bps | | 77 bps | | | | | Recovery rate | 20% | | 40% | | 37% | | | | | Yield | 5% | | 20% | | 11% | | | | | Loss severity | 0% | | 100% | | 50% | Other level 3 assets and liabilities, net(f) | 1,741 | | | | | | | | | |
(a)The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ. (b)Comprises U.S. GSE and government agency securities of $365 million, nonagency securities of $5 million and non-trading loans of $473 million. (c)Comprises nonagency securities of $14 million, trading loans of $65 million and non-trading loans of $1.2 billion. (d)Comprises trading loans of $803 million and non-trading loans of $559 million. (e)Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables. (f)Includes equity securities of $803 million including $606 million in Other assets, for which quoted prices are not readily available and the fair value is generally based on internal valuation techniques such as EBITDA multiples and comparable analysis. All other level 3 assets and liabilities are insignificant both individually and in aggregate. (g)Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100. (h)Forward equity price is expressed as a percentage of the current equity price. (i)Amounts represent weighted averages except for derivative related inputs where arithmetic averages are used. Changes in and ranges of unobservable inputs Refer to Note 2 of JPMorganChase’s 2024 Form 10-K for a discussion of the impact on fair value of changes in unobservable inputs and the relationships between unobservable inputs as well as a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions.
Changes in level 3 recurring fair value measurements The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three and six months ended June 30, 2025 and 2024. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable inputs to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. The Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Three months ended June 30, 2025 (in millions) | Fair value at Apr. 1, 2025 | Total realized/unrealized gains/(losses) | | | | | Transfers into level 3 | Transfers (out of) level 3 | | Fair value at Jun. 30, 2025 | Change in unrealized gains/(losses) related to financial instruments held at Jun. 30, 2025 | Purchases(f) | Sales | | Settlements(g) | | Assets:(a) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | Debt instruments: | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | U.S. GSEs and government agencies | $ | 390 | | | $ | 10 | | | $ | 28 | | $ | (49) | | | $ | (14) | | $ | — | | $ | — | | | $ | 365 | | | $ | 4 | | | Residential – nonagency | 5 | | | 6 | | | — | | (6) | | | — | | — | | — | | | 5 | | | — | | | Commercial – nonagency | 7 | | | — | | | — | | — | | | — | | — | | — | | | 7 | | | — | | | Total mortgage-backed securities | 402 | | | 16 | | | 28 | | (55) | | | (14) | | — | | — | | | 377 | | | 4 | | | Obligations of U.S. states and municipalities | 1 | | | — | | | — | | — | | | — | | — | | — | | | 1 | | | — | | | Non-U.S. government debt securities | 161 | | | 24 | | | 95 | | (105) | | | — | | 54 | | (24) | | | 205 | | | 30 | | | Corporate debt securities | 442 | | | 2 | | | 29 | | (86) | | | (5) | | 3 | | — | | | 385 | | | (1) | | | Loans | 803 | | | 17 | | | 377 | | (241) | | | (6) | | 157 | | (239) | | | 868 | | | 17 | | | Asset-backed securities | 10 | | | — | | | 2 | | — | | | — | | — | | — | | | 12 | | | — | | | Total debt instruments | 1,819 | | | 59 | | | 531 | | (487) | | | (25) | | 214 | | (263) | | | 1,848 | | | 50 | | | Equity securities | 133 | | | (27) | | | 151 | | (102) | | | — | | 63 | | (22) | | | 196 | | | (20) | | | Physical commodities | 14 | | | 10 | | | — | | — | | | — | | — | | — | | | 24 | | | 10 | | | Other | 239 | | | 30 | | | 15 | | — | | | (52) | | 2 | | (17) | | | 217 | | | 14 | | | Total trading assets – debt and equity instruments | 2,205 | | | 72 | | (c) | 697 | | (589) | | | (77) | | 279 | | (302) | | | 2,285 | | | 54 | | (c) | Net derivative receivables:(b) | | | | | | | | | | | | | | | | Interest rate | 994 | | | 393 | | | 34 | | (84) | | | 65 | | 5 | | 24 | | | 1,431 | | | 496 | | | Credit | (703) | | | (141) | | | (2) | | (7) | | | 10 | | 8 | | 27 | | | (808) | | | (142) | | | Foreign exchange | 298 | | | 333 | | | 28 | | (87) | | | (31) | | 21 | | (222) | | | 340 | | | 358 | | | Equity | (2,961) | | | 579 | | | 351 | | (757) | | | (711) | | 378 | | (83) | | | (3,204) | | | 215 | | | Commodity | 40 | | | 157 | | | 17 | | (74) | | | 30 | | (1) | | — | | | 169 | | | 160 | | | Total net derivative receivables | (2,332) | | | 1,321 | | (c) | 428 | | (1,009) | | | (637) | | 411 | | (254) | | | (2,072) | | | 1,087 | | (c) | Available-for-sale securities: | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | Commercial – nonagency | 8 | | | (1) | | | — | | — | | | — | | — | | — | | | 7 | | | — | | | Corporate debt securities | — | | | — | | | 92 | | — | | | — | | — | | — | | | 92 | | | — | | | Total available-for-sale securities | 8 | | | (1) | | | 92 | | — | | | — | | — | | — | | | 99 | | | — | | | Loans | 2,398 | | | 145 | | (c) | 76 | | (56) | | | (315) | | 152 | | (148) | | | 2,252 | | | 33 | | (c) | Mortgage servicing rights | 9,127 | | | 53 | | (d) | 85 | | 3 | | | (272) | | — | | — | | | 8,996 | | | 53 | | (d) | Other assets | 1,370 | | | (21) | | (c) | 57 | | (21) | | | (14) | | 35 | | (3) | | | 1,403 | | | (21) | | (c) | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Three months ended June 30, 2025 (in millions) | Fair value at Apr. 1, 2025 | Total realized/unrealized (gains)/losses | | | | | Transfers into level 3 | Transfers (out of) level 3 | | Fair value at Jun. 30, 2025 | Change in unrealized (gains)/losses related to financial instruments held at Jun. 30, 2025 | Purchases | Sales | Issuances | Settlements(g) | | Liabilities:(a) | | | | | | | | | | | | | | | | Deposits | $ | 1,949 | | | $ | 110 | | (c)(e) | $ | — | | $ | — | | $ | 261 | | $ | (211) | | $ | — | | $ | (10) | | | $ | 2,099 | | | $ | 108 | | (c)(e) | Short-term borrowings | 4,045 | | | 155 | | (c)(e) | — | | — | | 1,659 | | (1,722) | | 9 | | (10) | | | 4,136 | | | 131 | | (c)(e) | Trading liabilities – debt and equity instruments | 44 | | | (4) | | (c) | (7) | | 35 | | — | | (1) | | 10 | | (5) | | | 72 | | | — | | | Accounts payable and other liabilities | 36 | | | 5 | | (c) | — | | — | | — | | — | | — | | (1) | | | 40 | | | 5 | | (c) | Long-term debt | 36,482 | | | 2,443 | | (c)(e) | — | | — | | 7,087 | | (3,846) | | 27 | | (529) | | | 41,664 | | | 2,178 | | (c)(e) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Three months ended June 30, 2024 (in millions) | Fair value at Apr. 1, 2024 | Total realized/unrealized gains/(losses) | | | | | | | Transfers into level 3 | Transfers (out of) level 3 | Fair value at Jun. 30, 2024 | Change in unrealized gains/(losses) related to financial instruments held at Jun. 30, 2024 | Purchases(f) | Sales | | | Settlements(g) | | Assets:(a) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Debt instruments: | | | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | | | U.S. GSEs and government agencies | $ | 729 | | | $ | (1) | | | $ | 44 | | $ | (44) | | | | $ | (20) | | | $ | — | | $ | — | | | $ | 708 | | | $ | (1) | | | Residential – nonagency | 8 | | | 1 | | | — | | — | | | | — | | | — | | (4) | | | 5 | | | 1 | | | Commercial – nonagency | 12 | | | (1) | | | — | | — | | | | — | | | — | | — | | | 11 | | | (1) | | | Total mortgage-backed securities | 749 | | | (1) | | | 44 | | (44) | | | | (20) | | | — | | (4) | | | 724 | | | (1) | | | Obligations of U.S. states and municipalities | 7 | | | — | | | — | | — | | | | — | | | — | | — | | | 7 | | | — | | | Non-U.S. government debt securities | 173 | | | (3) | | | 41 | | (5) | | | | — | | | — | | (13) | | | 193 | | | (4) | | | Corporate debt securities | 570 | | | (4) | | | 86 | | (72) | | | | (151) | | | 4 | | (25) | | | 408 | | | (5) | | | Loans | 531 | | | 3 | | | 178 | | (131) | | | | (14) | | | 262 | | (138) | | | 691 | | | 2 | | | Asset-backed securities | 14 | | | — | | | — | | (5) | | | | (7) | | | — | | — | | | 2 | | | — | | | Total debt instruments | 2,044 | | | (5) | | | 349 | | (257) | | | | (192) | | | 266 | | (180) | | | 2,025 | | | (8) | | | Equity securities | 203 | | | (25) | | | 33 | | (51) | | | | — | | | 19 | | (57) | | | 122 | | | 3 | | | Physical commodities | 2 | | | 4 | | | 4 | | — | | | | — | | | — | | — | | | 10 | | | 4 | | | Other | 107 | | | 33 | | | 15 | | — | | | | (11) | | | 1 | | (1) | | | 144 | | | 34 | | | Total trading assets – debt and equity instruments | 2,356 | | | 7 | | (c) | 401 | | (308) | | | | (203) | | | 286 | | (238) | | | 2,301 | | | 33 | | (c) | Net derivative receivables:(b) | | | | | | | | | | | | | | | | | | Interest rate | 800 | | | 46 | | | 139 | | (41) | | | | 399 | |
| 58 | | (100) | | | 1,301 | | | 24 | | | Credit | 260 | | | 91 | | | — | | (1) | | | | (153) | | | (32) | | 15 | | | 180 | | | 89 | | | Foreign exchange | 24 | | | 128 | | | 43 | | (87) | | | | 35 | | | 24 | | 1 | | | 168 | | | 140 | | | Equity | (2,781) | | | 128 | |
| 247 | | (591) | | |
| (109) | |
| 38 | | 77 | |
| (2,991) | | | 216 | | | Commodity | (503) | | | 54 | | | 8 | | (52) | | | | 20 | | | (3) | | 4 | | | (472) | | | 60 | | | Total net derivative receivables | (2,200) | | | 447 | | (c) | 437 | | (772) | | |
| 192 | |
| 85 | | (3) | |
| (1,814) | | | 529 | | (c) | Available-for-sale securities: | | | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | | | Commercial – nonagency | — | | | — | | | — | | — | | | | — | | | — | | — | | | — | | | — | | | Corporate debt securities | — | | | — | | | — | | — | | | | — | | | — | | — | | | — | | | — | | | Total available-for-sale securities | — | | | — | | | — | | — | | | | — | | | — | | — | | | — | | | — | | | Loans | 2,901 | | | 72 | | (c) | 149 | | (183) | | | | (253) | | | 366 | | (59) | | | 2,993 | | | 58 | | (c) | Mortgage servicing rights | 8,605 | | | 119 | | (d) | 418 | | (32) | | | | (263) | | | — | | — | | | 8,847 | | | 119 | | (d) | Other assets | 811 | | | 37 | | (c) | 373 | | (13) | | | | (11) | | | 5 | | — | | | 1,202 | | | 37 | | (c) | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Three months ended June 30, 2024 (in millions) | Fair value at Apr. 1, 2024 | Total realized/unrealized (gains)/losses | | | | | | | Transfers into level 3 | Transfers (out of) level 3 | Fair value at Jun. 30, 2024 | Change in unrealized (gains)/losses related to financial instruments held at Jun. 30, 2024 | Purchases | Sales | | Issuances | Settlements(g) | | Liabilities:(a) | | | | | | | | | | | | | | | | | | Deposits | $ | 2,055 | | | $ | 14 | | (c)(e) | $ | — | | $ | — | | | $ | 265 | | $ | (407) | | | $ | 34 | | $ | (38) | | | $ | 1,923 | | | $ | 12 | | (c)(e) | Short-term borrowings | 2,206 | | | 68 | | (c)(e) | — | | — | | | 1,814 | | (1,360) | | | 1 | | (3) | | | 2,726 | | | 45 | | (c)(e) | Trading liabilities – debt and equity instruments | 37 | | | (37) | | (c) | (5) | | 55 | | | — | | — | | | 18 | | — | | | 68 | | | (37) | | (c) | Accounts payable and other liabilities | 48 | | | (8) | | (c) | (3) | | 28 | | | — | | — | | | 5 | | — | | | 70 | | | (8) | | (c) | Long-term debt | 28,678 | | | (36) | | (c)(e) | — | | — | | | 6,473 | | (4,121) | |
| 426 | | (134) | | | 31,286 | |
| (31) | | (c)(e) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Six months ended June 30, 2025 (in millions) | Fair value at Jan. 1, 2025 | Total realized/unrealized gains/(losses) | | | | | | | Transfers into level 3 | Transfers (out of) level 3 | Fair value at Jun. 30, 2025 | Change in unrealized gains/(losses) related to financial instruments held at Jun. 30, 2025 | Purchases(f) | Sales | | | Settlements(g) | | Assets:(a) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Debt instruments: | | | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | | | U.S. GSEs and government agencies | $ | 488 | | | $ | 13 | | | $ | 31 | | $ | (137) | | | | $ | (30) | | | $ | — | | $ | — | | | $ | 365 | | | $ | 2 | | | Residential – nonagency | 5 | | | 6 | | | — | | (6) | | | | — | | | — | | — | | | 5 | | | — | | | Commercial – nonagency | 10 | | | (3) | | | — | | — | | | | — | | | — | | — | | | 7 | | | (3) | | | Total mortgage-backed securities | 503 | | | 16 | | | 31 | | (143) | | | | (30) | | | — | | — | | | 377 | | | (1) | | | Obligations of U.S. states and municipalities | 1 | | | — | | | — | | — | | | | — | | | — | | — | | | 1 | | | — | | | Non-U.S. government debt securities | 152 | | | 36 | | | 171 | | (183) | | | | (1) | | | 54 | | (24) | | | 205 | | | 51 | | | Corporate debt securities | 390 | | | 9 | | | 128 | | (137) | | | | (10) | | | 13 | | (8) | | | 385 | | | 2 | | | Loans | 1,088 | | | 11 | | | 728 | | (455) | | | | (116) | | | 298 | | (686) | | | 868 | | | (5) | | | Asset-backed securities | 10 | | | — | | | 2 | | — | | | | — | | | — | | — | | | 12 | | | — | | | Total debt instruments | 2,144 | | | 72 | | | 1,060 | | (918) | | | | (157) | | | 365 | | (718) | | | 1,848 | | | 47 | | | Equity securities | 62 | | | (31) | | | 212 | | (142) | | | | — | | | 124 | | (29) | | | 196 | | | 3 | | | Physical commodities | 26 | | | — | | | — | | — | | | | (2) | | | — | | — | | | 24 | | | 6 | | | Other | 210 | | | (12) | | | 24 | | — | | | | (66) | | | 78 | | (17) | | | 217 | | | (53) | | | Total trading assets – debt and equity instruments | 2,442 | | | 29 | | (c) | 1,296 | | (1,060) | | | | (225) | | | 567 | | (764) | | | 2,285 | | | 3 | | (c) | Net derivative receivables:(b) | | | | | | | | | | | | | | | | | | Interest rate | 301 | | | 990 | | | 123 | | (201) | | | | 204 | |
| (55) | | 69 | | | 1,431 | | | 1,190 | | | Credit | (363) | | | (258) | | | 77 | | (7) | | | | (128) | | | (138) | | 9 | | | (808) | | | (216) | | | Foreign exchange | 20 | | | 565 | | | 91 | | (240) | | | | 38 | | | 94 | | (228) | | | 340 | | | 391 | | | Equity | (2,866) | | | 2,326 | |
| 623 | | (1,534) | | |
| (1,665) | |
| (199) | | 111 | |
| (3,204) | | | 1,573 | | | Commodity | (73) | | | 260 | | | 43 | | (136) | | | | 92 | | | — | | (17) | | | 169 | | | 309 | | | Total net derivative receivables | (2,981) | | | 3,883 | | (c) | 957 | | (2,118) | | |
| (1,459) | |
| (298) | | (56) | |
| (2,072) | | | 3,247 | | (c) | Available-for-sale securities: | | | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | | | Commercial – nonagency | 8 | | | (1) | | | — | | — | | | | — | | | — | | — | | | 7 | | | (1) | | | Corporate debt securities | — | | | — | | | 92 | | — | | | | — | | | — | | — | | | 92 | | | — | | | Total available-for-sale securities | 8 | | | (1) | | | 92 | | — | | | | — | | | — | | — | | | 99 | | | (1) | | | Loans | 2,416 | | | 174 | | (c) | 130 | | (128) | | | | (615) | | | 605 | | (330) | | | 2,252 | | | 102 | | (c) | Mortgage servicing rights | 9,121 | | | (74) | | (d) | 475 | | 7 | | | | (533) | | | — | | — | | | 8,996 | | | (74) | | (d) | Other assets | 1,344 | | | 11 | | (c) | 69 | | (52) | | | | (24) | | | 91 | | (36) | | | 1,403 | | | 12 | | (c) | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Six months ended June 30, 2025 (in millions) | Fair value at Jan. 1, 2025 | Total realized/unrealized (gains)/losses | | | | | | | Transfers into level 3 | Transfers (out of) level 3 | Fair value at Jun. 30, 2025 | Change in unrealized (gains)/losses related to financial instruments held at Jun. 30, 2025 | Purchases | Sales | | Issuances | Settlements(g) | | Liabilities:(a) | | | | | | | | | | | | | | | | | | Deposits | $ | 2,185 | | | $ | 162 | | (c)(e) | $ | — | | $ | — | | | $ | 623 | | $ | (836) | | | $ | — | | $ | (35) | | | $ | 2,099 | | | $ | 157 | | (c)(e) | Short-term borrowings | 3,476 | | | 204 | | (c)(e) | — | | — | | | 4,019 | | (3,534) | | | 19 | | (48) | | | 4,136 | | | 127 | | (c)(e) | Trading liabilities – debt and equity instruments | 46 | | | (14) | | (c) | (7) | | 46 | | | — | | (1) | | | 26 | | (24) | | | 72 | | | (14) | | (c) | Accounts payable and other liabilities | 76 | | | (3) | | (c) | — | | 1 | | | — | | — | | | — | | (34) | | | 40 | | | (3) | | (c) | Long-term debt | 34,564 | | | 2,233 | | (c)(e) | — | | — | | | 14,741 | | (8,937) | |
| 185 | | (1,122) | | | 41,664 | |
| 2,127 | | (c)(e) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Six months ended June 30, 2024 (in millions) | Fair value at Jan. 1, 2024 | Total realized/unrealized gains/(losses) | | | | | | | Transfers into level 3 | Transfers (out of) level 3 | Fair value at Jun. 30, 2024 | Change in unrealized gains/(losses) related to financial instruments held at Jun. 30, 2024 | Purchases(f) | Sales | | | Settlements(g) | | Assets:(a) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Debt instruments: | | | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | | | U.S. GSEs and government agencies | $ | 758 | | | $ | — | | | $ | 45 | | $ | (61) | | | | $ | (41) | | | $ | 7 | | $ | — | | | $ | 708 | | | $ | — | | | Residential – nonagency | 5 | | | — | | | — | | — | | | | — | | | 4 | | (4) | | | 5 | | | — | | | Commercial – nonagency | 12 | | | (2) | | | 1 | | — | | | | — | | | — | | — | | | 11 | | | (1) | | | Total mortgage-backed securities | 775 | | | (2) | | | 46 | | (61) | | | | (41) | | | 11 | | (4) | | | 724 | | | (1) | | | Obligations of U.S. states and municipalities | 10 | | | — | | | — | | — | | | | (2) | | | — | | (1) | | | 7 | | | — | | | Non-U.S. government debt securities | 179 | | | 2 | | | 92 | | (72) | | | | — | | | 7 | | (15) | | | 193 | | | (6) | | | Corporate debt securities | 484 | | | 7 | | | 300 | | (167) | | | | (181) | | | 8 | | (43) | | | 408 | | | 7 | | | Loans | 684 | | | 8 | | | 321 | | (330) | | | | (45) | | | 324 | | (271) | | | 691 | | | 5 | | | Asset-backed securities | 6 | | | — | | | 1 | | (5) | | | | (7) | | | 7 | | — | | | 2 | | | — | | | Total debt instruments | 2,138 | | | 15 | | | 760 | | (635) | | | | (276) | | | 357 | | (334) | | | 2,025 | | | 5 | | | Equity securities | 127 | | | (19) | | | 114 | | (81) | | | | — | | | 43 | | (62) | | | 122 | | | 5 | | | Physical commodities | 7 | | | 2 | | | 4 | | — | | | | (3) | | | — | | — | | | 10 | | | 2 | | | Other | 101 | | | 44 | | | 42 | | — | | | | (43) | | | 1 | | (1) | | | 144 | | | 42 | | | Total trading assets – debt and equity instruments | 2,373 | | | 42 | | (c) | 920 | | (716) | | | | (322) | | | 401 | | (397) | | | 2,301 | | | 54 | | (c) | Net derivative receivables:(b) | | | | | | | | | | | | | | | | | | Interest rate | 502 | | | (282) | | | 192 | | (84) | | | | 883 | |
| 187 | | (97) | | | 1,301 | | | (374) | | | Credit | 265 | | | 66 | | | — | | (16) | | | | (139) | | | (38) | | 42 | | | 180 | | | 208 | | | Foreign exchange | 62 | | | 131 | | | 77 | | (125) | | | | (87) | | | (29) | | 139 | | | 168 | | | 139 | | | Equity | (2,402) | | | (524) | |
| 568 | | (1,199) | | |
| 222 | |
| (11) | | 355 | |
| (2,991) | | | (6) | | | Commodity | (279) | | | (122) | | | 18 | | (120) | | | | 27 | | | (1) | | 5 | | | (472) | | | (123) | | | Total net derivative receivables | (1,852) | | | (731) | | (c) | 855 | | (1,544) | | |
| 906 | |
| 108 | | 444 | |
| (1,814) | | | (156) | | (c) | Available-for-sale securities: | | | | | | | | | | | | | | | | | | Mortgage-backed securities: | | | | | | | | | | | | | | | | | | Commercial – nonagency | — | | | — | | | — | | — | | | | — | | | — | | — | | | — | | | — | | | Corporate debt securities | — | | | — | | | — | | — | | | | — | | | — | | — | | | — | | | — | | | Total available-for-sale securities | — | | | — | | | — | | — | | | | — | | | — | | — | | | — | | | — | | | Loans | 3,079 | | | 109 | | (c) | 209 | | (205) | | | | (645) | | | 669 | | (223) | | | 2,993 | | | (3) | | (c) | Mortgage servicing rights | 8,522 | | | 397 | | (d) | 478 | | (27) | | | | (523) | | | — | | — | | | 8,847 | | | 397 | | (d) | Other assets | 758 | | | 66 | | (c) | 420 | | (22) | | | | (25) | | | 5 | | — | | | 1,202 | | | 66 | | (c) | | | | | | | | | | | | | | | | | | | | Fair value measurements using significant unobservable inputs | | | Six months ended June 30, 2024 (in millions) | Fair value at Jan. 1, 2024 | Total realized/unrealized (gains)/losses | | | | | | | Transfers into level 3 | Transfers (out of) level 3 | Fair value at Jun. 30, 2024 | Change in unrealized (gains)/losses related to financial instruments held at Jun. 30, 2024 | Purchases | Sales | | Issuances | Settlements(g) | | Liabilities:(a) | | | | | | | | | | | | | | | | | | Deposits | $ | 1,833 | | | $ | (15) | | (c)(e) | $ | — | | $ | — | | | $ | 792 | | $ | (610) | | | $ | 34 | | $ | (111) | | | $ | 1,923 | | | $ | (21) | | (c)(e) | Short-term borrowings | 1,758 | | | 69 | | (c)(e) | — | | — | | | 3,459 | | (2,557) | | | 1 | | (4) | | | 2,726 | | | 30 | | (c)(e) | Trading liabilities – debt and equity instruments | 37 | | | (40) | | (c) | (6) | | 57 | | | — | | — | | | 21 | | (1) | | | 68 | | | (67) | | (c) | Accounts payable and other liabilities | 52 | | | (12) | | (c) | (6) | | 31 | | | — | | — | | | 5 | | — | | | 70 | | | (12) | | (c) | Long-term debt | 27,726 | | | 515 | | (c)(e) | — | | — | | | 10,976 | | (7,972) | |
| 443 | | (402) | | | 31,286 | |
| 424 | | (c)(e) |
(a)Level 3 assets at fair value as a percentage of total Firm assets at fair value (including assets measured at fair value on a nonrecurring basis) were 1% and 2% at June 30, 2025 and December 31, 2024, respectively. Level 3 liabilities at fair value as a percentage of total Firm liabilities at fair value (including liabilities measured at fair value on a nonrecurring basis) were 6% and 9% at June 30, 2025 and December 31, 2024, respectively. (b)All level 3 derivatives are presented on a net basis, irrespective of the underlying counterparty. (c)Primarily reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans and lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income. (d)Changes in fair value for MSRs are reported in mortgage fees and related income. (e)Realized (gains)/losses due to DVA for fair value option elected liabilities are reported in principal transactions revenue, and were not material for the three and six months ended June 30, 2025 and 2024. Unrealized (gains)/losses are reported in OCI, and were $63 million and $(137) million for the three months ended June 30, 2025 and 2024, respectively, and $(10) million and $(97) million for the six months ended June 30, 2025 and 2024, respectively. (f)Loan originations are included in purchases. (g)Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, deconsolidations associated with beneficial interests in VIEs and other items. Level 3 analysis Consolidated balance sheets changes The following describes significant changes to level 3 assets since December 31, 2024, for those items measured at fair value on a recurring basis. Refer to Assets and liabilities measured at fair value on a nonrecurring basis on page 109 for further information on changes impacting items measured at fair value on a nonrecurring basis. Three and six months ended June 30, 2025 Level 3 assets were $25.5 billion at June 30, 2025, reflecting an increase of $1.3 billion from March 31, 2025, and an increase of $1.7 billion from December 31, 2024. The increase for the three and six months ended June 30, 2025 was predominantly driven by higher: •Gross derivative receivables of $1.4 billion and $2.0 billion, respectively, due to gains and purchases primarily offset by settlements. Refer to the sections below for additional information. Transfers between levels for instruments carried at fair value on a recurring basis For the three months ended June 30, 2025 and 2024, there were no significant transfers from level 2 into level 3 or from level 3 into level 2. For the six months ended June 30, 2025, significant transfers from level 2 into level 3 included the following: •$819 million and $1.0 billion of gross equity derivative receivables and gross equity derivative payables, respectively, as a result of a decrease in observability and an increase in the significance of unobservable inputs. For the six months ended June 30, 2025, significant transfers from level 3 into level 2 included the following: •$793 million and $904 million of gross equity derivative receivables and gross equity derivative payables, respectively, as a result of an increase in observability and a decrease in the significance of unobservable inputs. •$1.1 billion of long-term debt driven by an increase in observability and a decrease in the significance of unobservable inputs for structured notes. For the six months ended June 30, 2024, significant transfers from level 2 into level 3 included the following: •$759 million and $798 million of gross equity derivative receivables and gross equity derivative payables, respectively, as a result of a decrease in observability and an increase in the significance of unobservable inputs. For the six months ended June 30, 2024, significant transfers from level 3 into level 2 included the following: •$987 million of gross equity derivative payables as a result of an increase in observability and a decrease in the significance of unobservable inputs. All transfers are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur. Gains and losses The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the periods indicated. These amounts exclude any effects of the Firm’s risk management activities where the financial instruments are classified as level 1 and 2 of the fair value hierarchy. Refer to Changes in level 3 recurring fair value measurements rollforward tables on pages 102-107 for further information on these instruments. Three months ended June 30, 2025 •$1.6 billion of net gains on assets, predominantly driven by gains in net derivative receivables due to market movements. •$2.7 billion of net losses on liabilities, predominantly driven by losses in long-term debt due to market movements. Three months ended June 30, 2024 •$682 million of net gains on assets, predominantly driven by gains in net derivative receivables due to market movements and gains in MSR reflecting lower prepayment speeds on higher rates. •$1 million of net losses on liabilities, driven by losses in deposits and short-term borrowings predominantly offset by gains in trading liabilities - debt and equity instruments and long-term debt due to market movements. Six months ended June 30, 2025 •$4.0 billion of net gains on assets, driven by gains in net derivative receivables due to market movements. •$2.6 billion of net losses on liabilities, predominantly driven by losses in long-term debt due to market movements. Six months ended June 30, 2024 •$117 million of net losses on assets, driven by losses in net derivative receivables due to market movements largely offset by gains in loans due to market movements and gains in MSR reflecting lower prepayment speeds on higher rates. •$517 million of net losses on liabilities, driven by losses in long-term debt due to market movements. Refer to Note 14 for information on MSRs. Credit and funding adjustments — derivatives The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The FVA presented below includes the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time. | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | (in millions) | 2025 | | 2024 | | 2025 | | 2024 | Credit and funding adjustments: | | | | | | | | Derivatives CVA | $ | (72) | | | $ | (56) | | | $ | (117) | | | $ | 20 | | Derivatives FVA | (34) | | | (20) | | | (59) | | | 37 | | | | | | | | | | Refer to Note 2 of JPMorganChase’s 2024 Form 10-K for further information about both credit and funding adjustments, as well as information about valuation adjustments on fair value option elected liabilities.Assets and liabilities measured at fair value on a nonrecurring basis The following tables present the assets and liabilities held as of June 30, 2025 and 2024, for which nonrecurring fair value adjustments were recorded during the six months ended June 30, 2025 and 2024, by major product category and fair value hierarchy. | | | | | | | | | | | | | | | | | | | | | June 30, 2025 (in millions) | Fair value hierarchy | | Total fair value | Level 1 | Level 2 | | Level 3 | | Loans | $ | — | | $ | 1,048 | |
| $ | 637 | | | $ | 1,685 | | Other assets(a) | — | | 10 | | | 398 | | | 408 | | Total assets measured at fair value on a nonrecurring basis | $ | — | | $ | 1,058 | | | $ | 1,035 | | | $ | 2,093 | | Accounts payable and other liabilities | — | | — | | | 5 | | | 5 | | Total liabilities measured at fair value on a nonrecurring basis | $ | — | | $ | — | | | $ | 5 | | | $ | 5 | |
| | | | | | | | | | | | | | | | | | | | | June 30, 2024 (in millions) | Fair value hierarchy | | Total fair value | Level 1 | Level 2 | | Level 3 | | Loans | $ | — | | $ | 860 | |
| $ | 778 | | | $ | 1,638 | | Other assets | — | | 6 | | | 501 | |
| 507 | | Total assets measured at fair value on a nonrecurring basis | $ | — | | $ | 866 | | | $ | 1,279 | | | $ | 2,145 | | Accounts payable and other liabilities | — | | — | | | — | |
| — | | Total liabilities measured at fair value on a nonrecurring basis | $ | — | | $ | — | | | $ | — | | | $ | — | |
(a)Included equity securities without readily determinable fair values that were adjusted based on observable price changes in orderly transactions from an identical or similar investment of the same issuer (measurement alternative). Of the $398 million in level 3 assets measured at fair value on a nonrecurring basis as of June 30, 2025, $347 million related to equity securities adjusted based on the measurement alternative. These equity securities are classified as level 3 due to the infrequency of the observable prices and/or the restrictions on the shares. Nonrecurring fair value changes The following table presents the total change in value of assets and liabilities for which fair value adjustments have been recognized for the three and six months ended June 30, 2025 and 2024, related to assets and liabilities held at those dates. | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | (in millions) | 2025 | | 2024 | | 2025 | | 2024 | Loans | $ | (105) | | | $ | (105) | |
| $ | (139) | |
| $ | (149) | | Other assets(a) | (14) | | | (178) | |
| 14 | | | (215) | | Accounts payable and other liabilities | (4) | | | — | |
| (5) | | | — | | Total nonrecurring fair value gains/(losses) | $ | (123) | | | $ | (283) | | | $ | (130) | | | $ | (364) | |
(a)Included $(7) million and $(109) million for the three months ended June 30, 2025 and 2024, respectively, and $26 million and $(147) million for the six months ended June 30, 2025 and 2024, respectively, of net gains/(losses) as a result of the measurement alternative.
Equity securities without readily determinable fair values The Firm measures certain equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer (i.e., measurement alternative), with such changes recognized in other income. In its determination of the new carrying values upon observable price changes, the Firm may adjust the prices if deemed necessary to arrive at the Firm’s estimated fair values. Such adjustments may include adjustments to reflect the different rights and obligations of similar securities, and other adjustments that are consistent with the Firm’s valuation techniques for private equity direct investments. The following table presents the carrying value of equity securities without readily determinable fair values held as of June 30, 2025 and 2024, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes. These securities are included in the nonrecurring fair value tables when applicable price changes are observable. | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | As of or for the period ended, (in millions) | 2025 | | 2024 | | 2025 | | 2024 | Other assets | | | | | | | | Carrying value(a) | $ | 4,121 | | | $ | 3,564 | | | $ | 4,121 | | | $ | 3,564 | | Upward carrying value changes(b) | 26 | | | 10 | |
| 78 | | | 30 | Downward carrying value changes/impairment(c) | (33) | | | (119) | | | (52) | | | (177) | | | | | | | | | |
(a)The carrying value as of December 31, 2024 was $3.7 billion. The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes. (b)The cumulative upward carrying value changes between January 1, 2018 and June 30, 2025 were $1.2 billion. (c)The cumulative downward carrying value changes/impairment between January 1, 2018 and June 30, 2025 were $(1.5) billion. Included in other assets above is the Firm’s interest in approximately 18.6 million Visa Class B-2 common shares ("Visa B-2 shares") reflected in the Firm's principal investment portfolio at both June 30, 2025 and 2024. These shares are subject to certain transfer restrictions and are convertible into Visa Class A common shares (“Visa A shares”) at a specified conversion rate upon final resolution of certain litigation matters involving Visa. The conversion rate of Visa B-2 shares to Visa A shares was 1.5342 at June 30, 2025 and may be adjusted by Visa depending on developments related to the litigation matters. The outcome of those litigation matters, and the effect that the resolution of those matters may have on the conversion rate, is unknown. Accordingly, as of June 30, 2025, there is significant uncertainty regarding when the transfer restrictions on Visa B-2 shares may be terminated and what the final conversion rate for the Visa B-2 shares will be. As a result of these considerations, as well as differences in voting rights, Visa B-2 shares are not considered to be similar to Visa A shares, and are held at their nominal carryover basis. Separately, in connection with sales of Visa B shares prior to 2024, the Firm has entered into derivative instruments with the purchasers of the shares under which the Firm retains the risk associated with changes in the conversion rate. As of June 30, 2025, the Firm held derivative instruments associated with 11.6 million Visa B-2 shares related to Visa B share sales prior to 2024, which are all subject to similar terms and conditions. Refer to page 200 of JPMorganChase’s 2024 Form 10-K for further information. Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value The following table presents, by fair value hierarchy classification, the carrying values and estimated fair values at June 30, 2025 and December 31, 2024, of financial assets and liabilities, excluding financial instruments that are carried at fair value on a recurring basis, and their classification within the fair value hierarchy. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | | Estimated fair value hierarchy | | | | | Estimated fair value hierarchy | | (in billions) | Carrying value | Level 1 | Level 2 | Level 3 | | Total estimated fair value | | Carrying value | Level 1 | Level 2 | Level 3 | Total estimated fair value | Financial assets | | | | | | | | | | | | | Cash and due from banks | $ | 23.8 | | $ | 23.8 | | $ | — | | $ | — | | | $ | 23.8 | | | $ | 23.4 | | $ | 23.4 | | $ | — | | $ | — | | $ | 23.4 | | Deposits with banks | 396.6 | | 396.4 | | 0.2 | | — | | | 396.6 | | | 445.9 | | 445.8 | | 0.1 | | — | | 445.9 | | Accrued interest and accounts receivable | 124.3 | | — | | 124.2 | | 0.1 | | | 124.3 | | | 101.1 | | — | | 101.0 | | 0.1 | | 101.1 | | Federal funds sold and securities purchased under resale agreements | 22.8 | | — | | 22.8 | | — | | | 22.8 | | | 8.2 | | — | | 8.2 | | — | | 8.2 | | Securities borrowed | 127.3 | | — | | 127.3 | | — | | | 127.3 | | | 135.6 | | — | | 135.6 | | — | | 135.6 | | Investment securities, held-to-maturity | 260.6 | | 100.2 | | 139.1 | | — | | | 239.3 | | | 274.5 | | 97.4 | | 150.5 | | — | | 247.9 | | Loans, net of allowance for loan losses(a) | 1,333.7 | | — | | 263.0 | | 1,073.1 | | | 1,336.1 | | | 1,282.3 | | — | | 268.7 | | 1,007.8 | | 1,276.5 | | Other | 88.2 | | — | | 86.8 | | 1.6 | | | 88.4 | | | 82.7 | | — | | 81.3 | | 1.6 | | 82.9 | | Financial liabilities | | | | | | | | | | | | | Deposits | $ | 2,520.7 | | $ | — | | $ | 2,521.3 | | $ | — | | | $ | 2,521.3 | | | $ | 2,372.3 | | $ | — | | $ | 2,372.5 | | $ | — | | $ | 2,372.5 | | Federal funds purchased and securities loaned or sold under repurchase agreements | 69.9 | | — | | 69.9 | | — | | | 69.9 | | | 70.5 | | — | | 70.5 | | — | | 70.5 | | Short-term borrowings | 28.9 | | — | | 28.9 | | — | | | 28.9 | | | 26.4 | | — | | 26.3 | | — | | 26.3 | | Accounts payable and other liabilities(b) | 256.1 | | — | | 243.2 | | 11.9 | | | 255.1 | | | 232.8 | | — | | 219.6 | | 12.6 | | 232.2 | | Beneficial interests issued by consolidated VIEs | 27.7 | | — | | 27.7 | | — | | | 27.7 | | | 27.3 | | — | | 27.4 | | — | | 27.4 | | Long-term debt | 301.4 | | — | | 251.7 | | 51.8 | | | 303.5 | | | 300.6 | | — | | 251.2 | | 50.7 | | 301.9 | |
(a)Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. Carrying value of the loan takes into account the loan’s allowance for loan losses, which represents the loan’s expected credit losses over its remaining expected life. The difference between the estimated fair value and carrying value of a loan is generally attributable to changes in market interest rates, including credit spreads, market liquidity premiums and other factors that affect the fair value of a loan but do not affect its carrying value. (b)Excludes lending-related commitments disclosed in the table below. The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets. The carrying value and the estimated fair value of these wholesale lending-related commitments were as follows for the periods indicated. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | | Estimated fair value hierarchy | | | | Estimated fair value hierarchy | | (in billions) | Carrying value(a)(b) | Level 1 | Level 2 | Level 3 | Total estimated fair value | | Carrying value(a)(b) | Level 1 | Level 2 | Level 3 | Total estimated fair value | Wholesale lending-related commitments | $ | 3.5 | | $ | — | | $ | — | | $ | 4.6 | | $ | 4.6 | | | $ | 2.7 | | $ | — | | $ | — | | $ | 4.4 | | $ | 4.4 | |
(a)Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which is recognized at fair value at the inception of the guarantees. (b)Includes the wholesale allowance for lending-related commitments. The Firm does not estimate the fair value of consumer off-balance sheet lending-related commitments. In many cases, the Firm can reduce or cancel these commitments with or without notice to the borrower, as permitted by law, or in accordance with the contract. Refer to page 183 of JPMorganChase’s 2024 Form 10-K for a further discussion of the valuation of lending-related commitments.
|